These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 16549753)
1. Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53. Yip HT; Chopra R; Chakrabarti R; Veena MS; Ramamurthy B; Srivatsan ES; Wang MB Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):317-26. PubMed ID: 16549753 [TBL] [Abstract][Full Text] [Related]
2. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin. Wang MB; Yip HT; Srivatsan ES Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608 [TBL] [Abstract][Full Text] [Related]
3. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas. Taguchi T; Kato Y; Baba Y; Nishimura G; Tanigaki Y; Horiuchi C; Mochimatsu I; Tsukuda M Oncol Rep; 2004 Feb; 11(2):421-6. PubMed ID: 14719078 [TBL] [Abstract][Full Text] [Related]
4. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis. Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206 [TBL] [Abstract][Full Text] [Related]
5. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin. Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus. Kanavaros P; Stefanaki K; Rontogianni D; Papalazarou D; Sgantzos M; Arvanitis D; Vamvouka C; Gorgoulis V; Siatitsas I; Agnantis NJ; Bai M Histol Histopathol; 2001 Oct; 16(4):1005-12. PubMed ID: 11642719 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas. Kanavaros P; Bai M; Stefanaki K; Poussias G; Rontogianni D; Zioga E; Gorgoulis V; Agnantis NJ Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692 [TBL] [Abstract][Full Text] [Related]
9. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways. Park SH; Lee JH; Lee GB; Byun HJ; Kim BR; Park CY; Kim HB; Rho SB Cell Signal; 2012 Mar; 24(3):726-33. PubMed ID: 22142513 [TBL] [Abstract][Full Text] [Related]
10. Effects of cisplatin, 5-fluorouracil, and radiation on cell cycle regulation and apoptosis in the hypopharyngeal carcinoma cell line. Lee BJ; Chon KM; Kim YS; An WG; Roh HJ; Goh EK; Wang SG Chemotherapy; 2005 May; 51(2-3):103-10. PubMed ID: 15886465 [TBL] [Abstract][Full Text] [Related]
11. CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer. Bhattacharyya S; Sekar V; Majumder B; Mehrotra DG; Banerjee S; Bhowmick AK; Alam N; Mandal GK; Biswas J; Majumder PK; Murmu N Cell Oncol (Dordr); 2017 Apr; 40(2):145-155. PubMed ID: 28039610 [TBL] [Abstract][Full Text] [Related]
12. Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells. Katsuda K; Kataoka M; Uno F; Murakami T; Kondo T; Roth JA; Tanaka N; Fujiwara T Oncogene; 2002 Mar; 21(13):2108-13. PubMed ID: 11960384 [TBL] [Abstract][Full Text] [Related]
13. The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer. Roh JL; Ko JH; Moon SJ; Ryu CH; Choi JY; Koch WM Cancer Lett; 2012 Dec; 325(1):35-41. PubMed ID: 22634494 [TBL] [Abstract][Full Text] [Related]
14. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression. Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53. Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938 [TBL] [Abstract][Full Text] [Related]
16. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells. Schmidt M; Fan Z Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424 [TBL] [Abstract][Full Text] [Related]